Risk of microvascular complications over 30 years in latent autoimmune diabetes of adults compared with type 2 diabetes by Maddaloni, E, Coleman, R, Agbaje, O, Buzzetti, R, Holman, R

Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates by Mostafa, S, Coleman, R, Agbaje, O, Gray, A, Holman, R, Bethel, M

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes by Agbaje, O, Coleman, R, Hattersley, A, Pearson, E, Holman, R, MASTERMIND Consortium

Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients by Ballav, C, Dhere, A, Kennedy, I, Agbaje, O, Owen, K, White, S, Franklin, R, Hartman, B, Holst, J, Holman, J